1
L-glutamine Treatment in Patients With Diverticulosis
Condition(s):Diverticulosis, ColonicLast Updated:November 3, 2021Active, not recruiting
Glutamine as an Intervention: 241 Clinical Trials, Page 1 of 25
Hide Studies Not Open or Pending
2
Pharmacokinetics and Safety of Endari (L-glutamine) in Sickle Cell Disease Patients
Condition(s):Sickle Cell Disease; PharmacokineticsLast Updated:February 3, 2021Recruiting
3
The Effect of Pharmaceutical Grade L-glutamine (Endari) on Glycemic Control in Patients With Diabetes Mellitus Type II
Condition(s):Diabetes Mellitus, Type 2Last Updated:May 13, 2019Unknown status
4
Trial of Enteral Glutamine on Intestinal Permeability in Critically Ill Patients
Condition(s):Critical Illness; Enteral Nutrition; Intestinal PermeabilityLast Updated:April 10, 2018Completed
5
Glutamine Role in Preventing Vaso-occlusive Crisis Among SCD Patients
Condition(s):Sickle Cell DiseaseLast Updated:May 12, 2022Recruiting
6
L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer
Condition(s):Peripheral NeuropathyLast Updated:July 12, 2017Withdrawn
7
Glutamine for the Treatment of Patients With Irritable Bowel Syndrome
Condition(s):Diarrhea-Predominant Irritable Bowel SyndromeLast Updated:August 9, 2017Completed
8
Trial of Enteral Glutamine on Clinical Outcomes in Critically Ill Patients
Condition(s):Critical Illness; Enteral Nutrition; Multiple Organ Failure; Infection Complication; InflammationLast Updated:October 16, 2018Completed
9
The Role of Glutamine for Preventing Oxaliplatin-Induced Peripheral Neuropathy
Condition(s):Peripheral NeuropathyLast Updated:December 31, 2013Unknown status
10
A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin
Condition(s):Colorectal Carcinoma; Neoplasms, Colorectal; Colorectal Cancer; Colorectal Tumors; MetastasisLast Updated:February 24, 2016Withdrawn